论文部分内容阅读
目的观察口服茶碱缓释片联合吸入二丙酸倍氯米松干粉剂治疗支气管哮喘临床疗效。方法 2009年4月—2011年4月将78例支气管哮喘患者随机分为观察组40例与对照组38例,观察组给予口服茶碱缓释片并吸入二丙酸倍氯米松干粉剂,对照组仅给予二丙酸倍氯米松干粉剂吸入,8周后观察两组临床疗效。结果观察组显效13例,有效22例,总有效率87.50%;对照组显效7组,有效16例,总有效率60.53%,观察组疗效优于对照组。结论口服茶碱缓释片联合吸入二丙酸倍氯米松干粉剂治疗支气管哮喘疗效确切,值得临床推广。
Objective To observe the clinical efficacy of oral theophylline sustained-release tablets combined with beclometasone dipropionate dry powder in the treatment of bronchial asthma. Methods From April 2009 to April 2011, 78 patients with bronchial asthma were randomly divided into observation group (40 cases) and control group (38 cases). The observation group was given oral theophylline sustained-release tablets and inhaled beclomethasone dipropionate dry powder, while the control group Group only given beclometasone dipropionate dry powder inhalation, two weeks after the observation of clinical efficacy. Results The observation group was effective in 13 cases, effective in 22 cases, the total effective rate was 87.50%; the control group markedly effective in 7 groups, effective in 16 cases, the total effective rate was 60.53%. The observation group was better than the control group. Conclusion Oral theophylline sustained-release tablets combined with beclometasone dipropionate dry powder in the treatment of bronchial asthma is effective and worthy of clinical promotion.